Blog

For many decades, cancers have been described—and even treated—according to the type of organ from which the cancer arises, such as lung, breast or brain. But increasingly doctors are looking at genetic information to determine how to best treat their patients and increase the chances...

Like many people, Alice Beirne was unprepared to become a cancer caregiver. But with hope and determination, Alice and a team of relatives stepped in to help a loved one navigate through a year of cancer treatment and recovery. “It’s a journey, and every day...

Pacific Neuroscience Institute (PNI) and the Saint John’s Cancer Institute (the Institute) have a very close relationship. PNI physician scientists conduct research and clinical trials in collaboration with the Institute’s scientists and the Pacific Neuroscience Research Center of Excellence is housed in the Institute building. These physicians...

A review of new research and treatments for brain cancer in 2016  TJ was diagnosed with a stage III Astrocytoma brain tumor at the age of 14. Even after four brain surgeries, several courses of radiation over 5 years, many kinds of chemotherapy, experimental treatments,...

SANTA MONICA, CA – Daniel F. Kelly, M.D., professor of neuroscience and neurosurgery at the Saint John’s Cancer Institute and director of the Pacific Brain Tumor Center and Pituitary Disorders Center at Providence Saint John’s Health Center, was awarded the 2016 Hospital Physician Leadership Award...

We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...